Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 110,700 | 55,932 | 204,831 | 153,431 | 74,067 |
| Depreciation Amortization | 3,292 | 1,726 | 6,551 | 4,789 | 3,177 |
| Income taxes - deferred | N/A | N/A | -22,845 | -24,680 | N/A |
| Accounts receivable | -11,915 | 58 | -22,124 | -24,616 | -6,693 |
| Accounts payable and accrued liabilities | 4,079 | 1,022 | 826 | 1,009 | 5,029 |
| Other Working Capital | 15,705 | 10,084 | -36,419 | -45,918 | -18,041 |
| Other Operating Activity | 33,310 | 11,560 | 70,045 | 59,342 | 26,159 |
| Operating Cash Flow | $155,171 | $80,382 | $200,865 | $123,357 | $83,698 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -214,454 | -56,435 | -46,901 | -60,203 | -57,621 |
| PPE Investments | -10,713 | -7,148 | -11,516 | -9,377 | -7,673 |
| Investing Cash Flow | $-225,167 | $-63,583 | $-58,417 | $-69,580 | $-65,294 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 21,662 | 6,501 | 22,661 | 6,972 | 3,258 |
| Other Financing Activity | -17,068 | -16,960 | -13,956 | -13,933 | -13,928 |
| Financing Cash Flow | $4,594 | $-10,459 | $8,705 | $-6,961 | $-10,670 |
| Exchange Rate Effect | -3,162 | -1,331 | 286 | 923 | 1,230 |
| Beginning Cash Position | 496,304 | 496,304 | 344,865 | 344,865 | 344,865 |
| End Cash Position | 427,740 | 501,313 | 496,304 | 392,604 | 353,829 |
| Net Cash Flow | $-68,564 | $5,009 | $151,439 | $47,739 | $8,964 |
| Free Cash Flow | |||||
| Operating Cash Flow | 155,171 | 80,382 | 200,865 | 123,357 | 83,698 |
| Capital Expenditure | -10,713 | -7,148 | -11,951 | -9,812 | -8,108 |
| Free Cash Flow | 144,458 | 73,234 | 188,914 | 113,545 | 75,590 |